Lyntris's $1.78 Billion Debut Sets a Harder Defense-Tech Price
Lyntris priced below range, cut its IPO by seven million shares and fell 11.4% on debut. Public investors now want GAAP profit, lower leverage and core growth from defense tech, while private capital still entertains an Anduril valuation near $100 billion.
The downsized IPO exposed what public investors now demand from defense suppliers: GAAP profit, lower leverage and core growth, while private capital still entertains an Anduril valuation near $100 billion.
Lyntris's $17.50 Print
Lyntris's 11.4% first-day fall on 19 August 2026 marks a harder turn in defense-tech pricing. Reuters reported that the Trive Capital roll-up opened at $15.50 and finished its New York debut with a $1.78 billion valuation after pricing below range. Public investors saw the same demand for sensors, missile defense and command software that private capital sees. They discounted the earnings and ownership structure behind it.
Lyntris priced 17 million shares at $17.50 on 18 August, below the marketed range of $19 to $22 and seven million shares short of the original offering. The deal raised $297.5 million. The company's pricing release lists 5,714,286 primary shares and 11,285,714 shares sold by existing stockholders, leaving Lyntris with none of the proceeds from two-thirds of the offering. Its own proceeds will first repay approximately $60 million outstanding on a new revolving credit facility. Evercore ISI, Citigroup and Guggenheim Securities led the deal, and selling stockholders granted underwriters a 30-day option on another 2.55 million shares, all secondary.
The cut was severe. Renaissance Capital had scheduled a $492 million offering at a $2.36 billion market capitalization. IPO Bonanza's reading of the original terms found an 80% secondary structure, with Trive collecting roughly $394 million. Holders ultimately cut more than 7.8 million shares, while Lyntris increased its own sale from about 4.9 million shares to 5.7 million. Bloomberg Law calculated a $1.68 billion post-open value from the outstanding shares in the filings, against the $1.78 billion closing valuation.
Reuters places Lyntris in a wave of New York defense listings since April as boardrooms seek to capitalize on the Iran war. But investors have forced several issuers to trim deal sizes. Defense exposure opened the window. It did not set the price.
Frequently Asked Questions
What did Lyntris raise in its IPO and at what price?
Lyntris and selling stockholders sold 17 million shares at $17.50 on 18 August 2026, raising $297.5 million, below the marketed $19 to $22 range and seven million shares fewer than planned, per the company's pricing release and Reuters.
How did the stock trade on its first day?
Shares opened at $15.50 on the NYSE under ticker LYNX and closed down 11.4%, valuing the company at about $1.78 billion, per Reuters; Bloomberg Law calculated $1.68 billion on shares outstanding in the filings.
What does Lyntris actually make?
Per its S-1, sensor architecture and signal processing, RF and antenna hardware, radar and EW subsystems, and C2 software across maritime domain awareness, air and missile defense, and space ISR and communications, supplied as a merchant subsystem vendor to more than 200 programs.
Is Lyntris profitable?
Not on a GAAP basis: the S-1 shows net losses of $8.5 million in 2025 and $13 million in the first half of 2026, against adjusted EBITDA of $62.6 million and $37.8 million; revenue grew 34.6% in the first half to $241 million.
Why does the debut matter for defense tech more broadly?
It shows public investors pricing defense suppliers on GAAP profit, leverage and organic growth, the filter that pushed L3Harris to delay its Missile Solutions IPO to mid-2027 (per SpaceNews), while Reuters reported Anduril in talks at about $100 billion privately.
AI-generated summary, reviewed by an editor. More on our AI guidelines.
Below this point
- 200 Programs, Three Mission Lines
- $451 Million Revenue, $11.8 Million Loss
- Karman's 30.8% Margin
- Anduril's Reported $100 Billion Talks
- The 30-Day Greenshoe
